Cluster I MIBCs mainly include papilloma pathological phenotypes enriched in FGFR3 gene mutations; Clusters I and II highly express GATA3, FOXA1, UPK3A and luminal and uroplakin genes and are enriched in RBB2 mutations and estrogen receptor beta (ESR2). This evidence concerns the gene ESR2 and papilloma.